Anonymous
Guest
Anonymous
Guest
Any info on how many reps will be hired and when the hiring is going to take place? Thanks.
My expansion is occurring right now- next I leave pearls of wisdom for her
Ewwww.. Do you have it in your hand right now? Is it a purple throbber....
Any info on how many reps will be hired and when the hiring is going to take place? Thanks.
Gishman?
Have the DBL offers gone out yet? I was told last month to wait until December. My guess is that I didn't make the cut, but if that's the case, they should have cut me back then. Calls to HR are ignored. Maybe it's a blessing in disguise.
Offers out. Sorry you didn't make the cut. Heard spelling was a key competency.
The DBL decisions were made a long time ago. If you were one of the ones who was strung out over the last month, that sucks for you. They had to fill interview seats and it sounds like you were one of the suckers. Trust me, you are better off. This place has no class.
Not bitter at all. I just call it like I see it. I've been here long enough to know how they mistreat people. My guess is that you are part of the problem and incredibly insecure.
Dec 9th, 2014 · 0 Comment
Alkermes plc*(NASDAQ: ALKS) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of aripiprazole lauroxil, the company’s investigational, novel, once-monthly, long-acting injectable atypical antipsychotic for the treatment of schizophrenia. The data submitted as part of this NDA include the positive results from the pivotal phase 3 study assessing the efficacy and safety of aripiprazole lauroxil, in which aripiprazole lauroxil demonstrated significant improvements in schizophrenia symptoms, compared to placebo.